ClinicalTrials.Veeva

Menu

Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate?

U

University Hospital Muenster

Status

Unknown

Conditions

Colonic Polyp
Colonic Neoplasms
Colonoscopy
Colonic Adenoma

Treatments

Device: Endorings-2

Study type

Interventional

Funder types

Other

Identifiers

NCT03385434
2017-635-f-S

Details and patient eligibility

About

Screening colonoscopy for colorectal cancer is essential to diagnose and remove adenomas, precancerous stages of colorectal cancer. Unfortunately approximately 25 % of all adenomas are missed during the examination. Recently a new colonoscopy accessory, the Endorings-2 (EndoAid Ltd., Casearea, Israel), has been designed to improved the detection of adenomas during colonoscopy (adenoma detection rate).

Endorings-2 is a silicone-rubber device that is fitted on the colonoscope and is equipped with circular flexible silicon rings mechanically stretching the colonic folds during withdrawal.

This study aims to evaluate the efficacy of Endorings-2 to improve the adenoma detection rate in a prospective, blinded clinical trial. 292 patients with an indication for a screening colonoscopy shall be included (1:1 randomization in standard colonoscopy versus Endorings-2-assisted colonoscopy).

Enrollment

292 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with an indication for a screening colonoscopy.

Exclusion criteria

  • Patients under 18 years, pregnancy
  • Patients with prior colectomy or partial colectomy
  • Patients with a history of colorectal cancer
  • Patients with hereditary polyposis syndromes (FAP, HNPCC)
  • Patients with a stricture of the colon
  • Patients receiving anticoagulation prohibiting a colonoscopy
  • inability to have a patient education
  • bad conditions prohibiting a colonoscopy

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

292 participants in 2 patient groups

Endorings-assisted screening colonoscopy
Experimental group
Description:
146 patients with an indication for screening endoscopy will receive an Endorings-2-assisted colonoscopy.
Treatment:
Device: Endorings-2
Standard screening colonoscopy
No Intervention group
Description:
146 patients with an indication for screening endoscopy will receive a standard colonoscopy.

Trial contacts and locations

1

Loading...

Central trial contact

Arne Bokemeyer, MD; Frank Lenze, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems